Verve Therapeutics Inc (VERV) stock is lower by -51.23% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives VERV stock a score of 33 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 2. VERV's rank also includes a long-term technical score of 4.
VERV has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VERV!
Verve Therapeutics Inc (VERV) stock has risen 1.16% while the S&P 500 is lower by -0.18% as of 12:00 PM on Thursday, Nov 30. VERV has gained $0.13 from the previous closing price of $11.20 on volume of 509,378 shares. Over the past year the S&P 500 has gained 11.33% while VERV is lower by -51.23%. VERV lost -$3.10 per share in the over the last 12 months.
Click Here to get the full Stock Report for Verve Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
